Association between methylenetetrahydrofolate reductase polymorphism C677T and risk of chronic myeloid leukemia in Serbian population

Leukemia and Lymphoma

Volumn 53, Issue 7, 2012, Pages 1327-1330

  Jakovljevic, Ksenija ^a   Malisic, Emina ^a   Cavic, Milena ^a   Radulovic, Sinisa ^a   Jankovic, Radmila ^a  

^a INSTITUTE FOR ONCOLOGY AND RADIOLOGY OF SERBIA   (Serbia)

Author keywords

CML; genotyping; MTHFR polymorphisms

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); IMATINIB;

ADULT; AGED; ARTICLE; CANCER RISK; CASE CONTROL STUDY; CHRONIC MYELOID LEUKEMIA; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ADULT; AGED; CASE-CONTROL STUDIES; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; LEUKEMIA, MYELOGENOUS, CHRONIC, BCR-ABL POSITIVE; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SERBIA; YOUNG ADULT;

EID: 84862736567     PISSN: 10428194     EISSN: 10292403     Source Type: Journal    
DOI: 10.3109/10428194.2011.645210     Document Type: Article

References (24)

1. Quintas-Cardama A, Cortes JE. Chronic myeloid leukemia: diagnosis and treatment. Mayo Clin Proc 2006;81:973-988. (Pubitemid 43993489)
2. Gabert J, Beillard E, van der Velden VHJ, et al. Standardization and quality control studies of " real-time " quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia-a Europe Against Cancer Program. Leukemia 2003;17:2318-2357. (Pubitemid 38072573)
3. Frazer R, Irvine AE, McMullin MF. Chronic myeloid leukaemia in the 21st century. Ulster Med J 2007;76:8-17. (Pubitemid 46157342)
4. Skibola CF, Smith MT, Kane E, et al. Polymorphisms in the methylenetetrahydrofolate reductase gene are associated with susceptibility to acute leukemia in adults. Proc Natl Acad Sci 1999;96:12810-12815. (Pubitemid 29513584)
5. Blount BC, Mack MM, Wehr CM, et al. Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage. Proc Natl Acad Sci USA 1997;94:3290-3295.
6. Goyette P, Sumner JS, Milos R, et al. Human methylenetetrahydrofolate reductase: isolation of cDNA, mapping and mutation identification. Nat Genet 1994;7:195-200. (Pubitemid 24174661)
7. Frosst P, Blom HJ, Milos R, et al. A candidate genetic risk factor for vascular disease: a common mutation in methylenetetrahydrofolate reductase. Nat Genet 1995;10:111-113.
8. Ueland PM, Hustad S, Schneede J, et al. Biological and clinical implications of the MTHFR C677T polymorphism. Trends Pharmacol Sci 2001;22:195-201. (Pubitemid 32244306)
9. Wiemels JL, Smith RN, Taylor GM, Eden et al. Methylenetetrahydrofolate reductase (MTHFR) polymorphisms and risk of molecularly defined subtypes of childhood acute leukemia. Proc Natl Acad Sci USA 2001;27:4004-4009. (Pubitemid 32249888)
10. Franco RF, Simoes BP, Tone LG, et al. The methylenetetrahydrofolate reductase C677T gene polymorphism decreases the risk of childhood acute lymphocytic leukaemia. Br J Haematol 2001;115:616-618. (Pubitemid 34015653)
11. Krajinovic M, Lamothe S, Labuda D, et al. Role of MTHFR genetic polymorphisms in the susceptibility to childhood acute lymphoblastic leukemia. Blood 2004;103:252-257. (Pubitemid 38029946)
12. Zanrosso CW, Hatagima A, Emerenciano M, et al. The role of methylenetetrahydrofolate reductase in acute lymphoblastic leukemia in a Brazilian mixed population. Leuk Res 2006;30:477-481. (Pubitemid 43254969)
13. Moon HW, Kim TY, Oh BR, et al. MTHFR 677CC/1298CC genotypes are highly associated with chronic myelogenous leukemia: a case-control study in Korea. Leuk Res 2007;31:1213-1217.
14. Barbosa CG, Souza CL, Pereira de Moura Neto J, et al. Methylenetetrahydrofolate reductase polymorphisms in myeloid leukemia patients from Northeastern Brazil. Gen Mol Biol 2008;31:29-32.
15. Schnakenberg E, Mehles A, Cario G, et al. Polymorphisms of methylenetetrahydrofolate reductase (MTHFR) and susceptibility to pediatric acute lymphoblastic leukemia in a German study population. BMC Med Genet 2005;6:23.
16. Nisevic I, Dinic J, Nikolic A, et al. MTHFR C677T polymorphism in chronic pancreatitis and pancreatic adenocarcinoma. Cell Biochem Funct 2008;26:659-663.
17. Novaković I, Damnjanović T, Sango V, et al. Polymorphism C677T in the gene encoding for methylenetetrahydrofolate reductase in different vascular disorders. Paper presented at IV Congress of the Serbian Genetic Society. 1-5 June 2009. Tara, Serbia.
18. Damnjanovic T, Milicevic R, Novkovic T, et al. Association between the methylenetetrahydrofolate reductase polymorphisms and risk of acute lymphoblastic leukemia in Serbian children. J Pediatr Hematol Oncol 2010;32:148-150.
19. Crossed D signorćević V, Nikolić A, Ljujić M, et al. Combined effect of GSTM1 gene deletion, GSTT1 gene deletion and MTHFR C677T mutation in male infertility. Arch Biol Sci 2010;62:525-530.
20. Toffoli G, Rossi D, Gaidano G, et al. Methylenetetrahydrofolate reductase genotype in diffuse large B-cell lymphomas with and without hypermethylation of the DNA repair gene O6-methylguanine DNA methyltransferase. Int J Biol Markers 2003;18:218-221. (Pubitemid 37254288)
21. Gnani A, Soverini S, Colarossi S, et al. Genetic polymorphisms in the methylenetetrahydrofolate reductase gene associated with chronic myeloid leukemia. Haematologica 2007;92(Suppl. 2): Abstract 0536.
22. Guéant-Rodriguez RM, Guéa nt JL, Debard R, et al. Prevalence of methylenetetrahydrofolate reductase 677T and 1298C alleles and folate status: a comparative study in Mexican, West African, and European populations. Am J Clin Nutr 2006;83:701-707.
23. Robien K, Ulrich CM, Bigler J, et al. Methylenetetrahydrofolate reductase genotype affects risk of relapse after hematopoietic cell transplantation for chronic myelogenous leukemia. Clin Cancer Res 2004;10:7592-7598. (Pubitemid 39557521)
24. Robien K, Ulrich CM. 5,10-Methylenetetrahydrofolate reductase polymorphisms and leukemia risk: a HuGE minireview. Am J Epidemiol 2003;157:571-582. (Pubitemid 36368527)